Similar articles

• Long-acting beta agonists in asthma therapy.

  Rissmiller RW Jr, Larj MJ, Peters SP. Rissmiller RW Jr, et al. Curr Allergy Asthma Rep. 2004 Mar;4(2):91-2. doi: 10.1007/s11882-004-0049-6. Curr Allergy Asthma Rep. 2004. PMID: 14769255 No abstract available.
• Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet).

  Verberne AA, de Jongste JC. Verberne AA, et al. Pediatr Pulmonol. 2000 Mar;29(3):169-71. doi: 10.1002/(sici)1099-0496(200003)29:3<169::aid-ppul2>3.0.co;2-0. Pediatr Pulmonol. 2000. PMID: 10686035 No abstract available.
• Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial.

  Singhania N, Dhamija R, Lodha R, Kabra SK. Singhania N, et al. Indian Pediatr. 2008 Mar;45(3):225-8. Indian Pediatr. 2008. PMID: 18367770 Clinical Trial.
• Long-acting beta 2-agonists.

  Tattersfield AE. Tattersfield AE. Clin Exp Allergy. 1992 Jun;22(6):600-5. doi: 10.1111/j.1365-2222.1992.tb00175.x. Clin Exp Allergy. 1992. PMID: 1356604 Review. No abstract available.
• Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?

  Devoy MA, Fuller RW, Palmer JB. Devoy MA, et al. Chest. 1995 Apr;107(4):1116-24. doi: 10.1378/chest.107.4.1116. Chest. 1995. PMID: 7705125 Review. No abstract available.